We've demonstrated that treatment timing fundamentally determines therapeutic efficacy in combination cancer therapies. Published in Advanced Science, this work establishes that a 36-hour interval between siRNA delivery and photothermal treatment doubles tumor reduction compared to non-optimized protocols. This finding has immediate implications for how we schedule any gene silencing combination therapy.